Align Technology ALGN · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
174.26
+4.98%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Align Technology
From its filings with the US Securities and Exchange Commission
Align Technology is based in Tempe, Arizona and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ALGN. It is a member of the S&P 500. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $4.03bn and net income of $410.4m. At that date it held total assets of $6.23bn and shareholders' equity of $4.05bn. By region, U.S. accounted for 41.2%, followed by Other International at 36.0% and Switzerland at 22.8%.
Our corporate headquarters are located at 410 North Scottsdale Road, Suite 1300, Tempe, Arizona 85288. Our telephone number is 602-742-2000. Our internet address is www.aligntech.com. Our Americas regional headquarters is located in Raleigh, North Carolina, U.S.A.; our European, Middle East and Africa (“EMEA”) regional headquarters is located in Rotkreuz, Switzerland; and our Asia Pacific (“APAC”) regional headquarters is located in Singapore.
We have two operating segments: (1) Clear Aligner and (2) Imaging Systems and CAD/CAM Services (“Systems and Services”). For the year ended December 31, 2025, Clear Aligner net revenues represented approximately 80% of worldwide net revenues, while Systems and Services net revenues represented the remaining 20%. We sell the majority of our products and services directly through a dedicated and specialized sales force to our customers: orthodontists, GPs, including prosthodontists, periodontists, oral surgeons and dental laboratories. We also sell through sales agents and distributors in certain countries. In addition, we sell directly to dental support organizations (“DSOs”) who contract with dental practices to provide critical business management and support, including non-clinical operations. We also sell our products to dental laboratories who use our products to manufacture or customize their own products for licensed dentists.
Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 26 Jan 2001
- Employees
- 20,290
- Website
- aligntech.com ↗
- Head office
- 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, AZ, 85288
- Incorporated in
- DE
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Charles LarkinIndependent Chairman of the Board$499,775
- Mr. Joseph HoganPresident, Chief Executive Officer, Director, since 2015$27.3m
- Mr. John MoriciChief Financial Officer, Executive Vice President - Global Finance$6.4m
- Mr. Stuart HockridgeExecutive Vice President, Global Human Resources$3.5m
- Ms. Julie ColettiExecutive Vice President, Chief Legal and Regulatory Officer$4.8m
- Mr. Britt VitaloneDirector
- Mr. Kevin ConroyIndependent Director$361,016
- Mr. Kevin DallasIndependent Director$376,599
- Mr. Joseph LacobIndependent Director$368,933
- Mr. George MorrowIndependent Director$381,766
- Ms. Anne MyongIndependent Director$390,266
- Ms. Mojdeh PoulIndependent Director$361,016
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 50
- Environment
- 37
- Social
- 48
- Governance
- 64
- Direct emissions (scope 1)
- 3,900 t
- Energy emissions (scope 2)
- 39,200 t
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Innovative and patented technology: Align Technology Inc holds proprietary technology and patents, allowing them to dominate the clear aligner market with their Invisalign product.
- Strong brand recognition: The Invisalign brand is widely recognized and trusted by both consumers and dental professionals, giving Align Technology a competitive advantage.
- Global reach: The company has a strong international presence, expanding its clear aligner solutions across various markets worldwide.
Weaknesses
- Costly treatment: Invisalign treatment can be expensive compared to traditional braces, potentially limiting its accessibility for certain demographics.
- Dependency on dental professionals: Align Technology relies heavily on dentists and orthodontists to promote and administer their products, which may pose challenges in areas with limited access to specialized dental care.
- Limited product diversification: While Invisalign is highly successful, the company has limited product offerings, which may make them vulnerable to fluctuations in market demand or new competing technologies.
Opportunities
- Growing orthodontic market: The orthodontic industry continues to expand, with increasing demand for more aesthetically pleasing and convenient teeth-straightening solutions, presenting opportunities for Align Technology.
- Technological advancements: Ongoing advancements in digital scanning, 3D printing, and material science could potentially enhance Align Technology's product offerings and improve treatment efficiency.
- Untapped markets: There are still regions around the world where the clear aligner market penetration is relatively low, providing opportunities for Align Technology to expand their market share.
Threats
- Intense competition: The clear aligner industry is becoming increasingly competitive, with established companies and new entrants vying for market share.
- Economic downturns: During economic recessions or downturns, consumers may be more hesitant to invest in elective dental treatments like Invisalign, potentially impacting Align Technology's revenue.
- Regulatory challenges: Align Technology operates in various countries, each with its own regulatory framework. Changes in regulations or compliance requirements may pose challenges or barriers to entry.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.